Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes-Reference-Cited by-同舟云学术

Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes

Published:2014-08 Issue: Volume:188 Page:87-98
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Papademetriou Iason,Tsinas Zois,Hsu Janet,Muro Silvia

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Targeted drugs and nanomedicine: present and future;Debbage;Curr. Pharm. Des.,2009

2. Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges;Duncan;Mol. Pharm.,2012

3. The origins and evolution of “controlled” drug delivery systems;Hoffman;J. Control. Release,2008

4. Challenges in design and characterization of ligand-targeted drug delivery systems;Muro;J. Control. Release,2012

5. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging;Parveen;Nanomedicine,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-targeting galactose-functionalized hyaluronic acid modified lipid nanoparticles delivering silybin for alleviating alcoholic liver injury;International Journal of Pharmaceutics;2024-09

2. Anti – intercellular adhesion molecule-1(ICAM-1) nanoparticles for damaged endothelium to treat venous thromboembolism;Journal of Dispersion Science and Technology;2024-06-26

3. Enhanced efficiency of melatonin by stepwise-targeting strategy for acute lung injury;Frontiers in Bioengineering and Biotechnology;2022-09-07

4. Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases;Frontiers in Pharmacology;2022-08-30

5. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin;Nanoscale;2022